HTA bodies

GIST Care Looks Beyond First-Generation KIT Control

Pancreatic Cancer Finally Gets a RAS Moment

GSK’s Nuvalent Deal Turns Lung Cancer Precision Into a $10.6 Billion Access Race

Multiple System Atrophy Gets a Clearer FDA Pathway

ADA 2026 findings show diabetes drugs are no longer just chasing glucose

Oral SERDs Face the Hard Test: Where Do They Actually Fit?

Prostate Cancer Value Starts Counting Cognition

China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone

The ASCO Drug Race Still Runs Through Genomic Testing
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
